Page 1005 - Williams Hematology ( PDFDrive )

980 Part VII: Neutrophils, Eosinophils, Basophils, and Mast Cells Chapter 63: Basophils, Mast Cells, and Related Disorders 981

98. Marichal T, Starkl P, Reber LL, et al: A beneficial role for immunoglobulin E in host 137. Arber DA, Brunning RD, Orazi A, et al: Acute myeloid leukaemia, not otherwise speci-
defense against honeybee venom. Immunity 39:963–975, 2013. fied, in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, edited
99. Akahoshi M, Song CH, Piliponsky AM, et al: Mast cell chymase reduces the toxicity of by Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman
Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. J JW. p 130. IARC Press, Lyon, 2008.
Clin Invest 121:4180–4191, 2011. 138. Staal-Viliare A, Latger-Cannard V, Rault JP, et al: A case of de novo acute basophilic leu-
100. Palm NW, Rosenstein RK, Medzhitov R: Allergic host defences. Nature 484:465–472, 2012. kaemia: Diagnostic criteria and review of the literature. Ann Biol Clin (Paris) 64:361–
101. Brandt EB, Strait RT, Hershko D, et al: Mast cells are required for experimental oral 365, 2006.
allergen-induced diarrhea. J Clin Invest 112:1666–1677, 2003. 139. Staal-Viliare A, Latger-Cannard V, Didion J, et al: CD203c+/CD117–, an useful pheno-
102. Shelley WB, Parnes HM: The absolute basophil count. JAMA 192:368–370, 1965. type profile for acute basophilic leukaemia diagnosis in cases of undifferentiated blasts.
103. Thonnard-Neumann E: Studies of basophils, variations with age and sex. Acta Haema- Leuk Lymphoma 48:439–441, 2007.
tol 30:221–228, 1963. 140. Dastugue N, Duchayne E, Kuhlein E, et al: Acute basophilic leukaemia and transloca-
104. Chavance M, Herbeth B, Kauffmann F: Seasonal patterns of circulating basophils. Int tion t(X;6)(p11;q23). Br J Haematol 98:170–176, 1997.
Arch Allergy Appl Immunol 86:462–464, 1988. 141. Quelen C, Lippert E, Struski S, et al: Identification of a transforming MYB-GATA1
105. Shelley WB, Juhlin L: A new test for detecting anaphylactic sensitivity: The basophil fusion gene in acute basophilic leukemia: A new entity in male infants. Blood 117:5719–
reaction. Nature 191:1056–1058, 1961. 5722, 2011.
106. Grattan CE, Dawn G, Gibbs S, et al: Blood basophil numbers in chronic ordinary urti- 142. Pearson MG, Vardiman JW, Le Beau MM, et al: Increased numbers of marrow basophils
caria and healthy controls: Diurnal variation, influence of loratadine and prednisolone may be associated with a t(6;9) in ANLL. Am J Hematol 18:393–403, 1985.
and relationship to disease activity. Clin Exp Allergy 33:337–341, 2003. 143. Horsman DE, Kalousek DK: Acute myelomonocytic leukemia (AML-M4) and translo-
107. Juhlin L: Basophil and eosinophil leukocyted in various internal disorders. Acta Med cation t(6;9)(p23);q34): Two additional patients with prominent myelodysplasia. Am J
Scand 174:249–254, 1963. Hematol 26:77–82, 1987.
108. Juhlin L: The effect of corticotrophin and corticosteroids on the basophil and eosino- 144. Matsuura Y, Sato N, Kimura F, et al: An increase in basophils in a case of acute myelo-
phil granulocytes. Acta Haematol 29:157–165, 1963. monocytic leukaemia associated with marrow eosinophilia and inversion of chromo-
109. Malveaux FJ, Conroy MC, Adkinson NF Jr, et al: IgE receptors on human basophils. some 16. Eur J Haematol 39:457–461, 1987.
Relationship to serum IgE concentration. J Clin Invest 62:176–181, 1978. 145. Hoyle CF, Sherrington P, Hayhoe FG: Translocation (3;6)(q21;p21) in acute myeloid
110. Lantz CS, Yamaguchi M, Oettgen HC, et al: IgE regulates mouse basophil FcεRI expres- leukemia with abnormal thrombopoiesis and basophilia. Cancer Genet Cytogenet
sion in vivo. J Immunol 158:2517–2521, 1997. 30:261–267, 1988.
111. Juhlin L: Basophil leukocytes in ulcerative colitis. Acta Med Scand 173:351–359, 1963. 146. Nacheva EP, Grace CD, Brazma D, et al: Does BCR/ABL1 positive acute myeloid leu-
112. Athreya BH, Moser G, Raghavan TE: Increased circulating basophils in juvenile rheu- kaemia exist? Br J Haematol 161:541–550, 2013.
matoid arthritis. A preliminary report. Am J Dis Child 129:935–937, 1975. 147. Alsabeh R, Brynes RK, Slovak ML, et al: Acute myeloid leukemia with t(6;9) (p23;q34):
113. Fredericks RE, Moloney WC: The basophilic granulocyte. Blood 14, 1959. Association with myelodysplasia, basophilia, and initial CD34 negative immunopheno-
114. Spiers AS, Bain BJ, Turner JE: The peripheral blood in chronic granulocytic leukaemia. type. Am J Clin Pathol 107:430–437, 1997.
Study of 50 untreated Philadelphia-positive cases. Scand J Haematol 18:25–38, 1977. 148. Slovak ML, Gundacker H, Bloomfield CD, et al: A retrospective study of 69 patients
115. Kamada N, Uchino H: Chronologic sequence in appearance of clinical and laboratory with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative
findings characteristic of chronic myelocytic leukemia. Blood 51:843–850, 1978. for rare “poor prognosis” myeloid malignancies. Leukemia 20:1295–1297, 2006.
116. Drewinko B, Bollinger P, Brailas C, et al: Flow cytochemical patterns of white blood 149. Oyarzo MP, Lin P, Glassman A, et al: Acute myeloid leukemia with t(6;9)(p23;q34) is
cells in human haematopoietic malignancies. II. Chronic leukaemias. Br J Haematol associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol
67:157–165, 1987. 122:348–358, 2004.
117. Denburg JA, Browman G: Prognostic implications of basophil differentiation in chronic 150. Le Beau MM, Larson RA, Bitter MA, et al: Association of an inversion of chromosome
myeloid leukemia. Am J Hematol 27:110–114, 1988. 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique
118. Goh KO, Anderson FW: Cytogenetic studies in basophilic chronic myelocytic leuke- cytogenetic-clinicopathological association. N Engl J Med 309:630–636, 1983.
mia. Arch Pathol Lab Med 103:288–290, 1979. 151. Lewis RA, Goetzl EJ, Wasserman SI, et al: The release of four mediators of immediate
119. Denburg JA, Wilson WE, Goodacre R, et al: Chronic myeloid leukaemia: Evidence for hypersensitivity from human leukemic basophils. J Immunol 114:87–92, 1975.
basophil differentiation and histamine synthesis from cultured peripheral blood cells. 152. Travis WD, Li CY, Bergstralh EJ, et al: Systemic mast cell disease. Analysis of 58 cases
Br J Haematol 45:13–21, 1980. and literature review. Medicine (Baltimore) 67:345–368, 1988.
120. Parkin JL, McKenna RW, Brunning RD: Philadelphia chromosome-positive blastic 153. Tsai M, Shih LS, Newlands GF, et al: The rat c-kit ligand, stem cell factor, induces the
leukaemia: Ultrastructural and ultracytochemical evidence of basophil and mast cell development of connective tissue-type and mucosal mast cells in vivo. Analysis by ana-
differentiation. Br J Haematol 52:663–677, 1982. tomical distribution, histochemistry, and protease phenotype. J Exp Med 174:125–131,
121. Zucker-Franklin D: Ultrastructural evidence for the common origin of human mast 1991.
cells and basophils. Blood 56:534–540, 1980. 154. Irani AA, Garriga MM, Metcalfe DD, et al: Mast cells in cutaneous mastocytosis: Accu-
122. Soler J, O’Brien M, de Castro JT, et al: Blast crisis of chronic granulocytic leukemia with mulation of the MCTC type. Clin Exp Allergy 20:53–58, 1990.
mast cell and basophilic precursors. Am J Clin Pathol 83:254–259, 1985. 155. Schwartz LB, Metcalfe DD, Miller JS, et al: Tryptase levels as an indicator of mast-cell
123. Weil SC, Hrisinko MA: A hybrid eosinophilic-basophilic granulocyte in chronic gran- activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316:1622–1626,
ulocytic leukemia. Am J Clin Pathol 87:66–70, 1987. 1987.
124. Gabriel LC, Escribano LM, Marie JP, et al: Peroxidase activity in circulating mast cells in 156. Weidner N, Horan RF, Austen KF: Mast-cell phenotype in indolent forms of mastocy-
blast crisis of chronic granulocytic leukemia. Comparative studies with basophils and tosis. Ultrastructural features, fluorescence detection of avidin binding, and immun-
cutaneous mast cells. Am J Clin Pathol 86:212–219, 1986. ofluorescent determination of chymase, tryptase, and carboxypeptidase. Am J Pathol
125. Youman JD, Taddeini L, Cooper T: Histamine excess symptoms in basophilic chronic 140:847–857, 1992.
granulocytic leukemia. Arch Intern Med 131:560–562, 1973. 157. Weidner N, Austen KF: Heterogeneity of mast-cells at multiple body sites-fluorescent
126. Rosenthal S, Schwartz JH, Canellos GP: Basophilic chronic granulocytic leukaemia determination of avidin binding and immunofluorescent determination of chymase,
with hyperhistaminaemia. Br J Haematol 36:367–372, 1977. tryptase, and carboxypeptidase content. Pathol Res Pract 189:156–162, 1993.
127. Valimaki M, Vuopio P, Salaspuro M: Plasma histamine and serum pepsinogen I con- 158. Lavker RM, Schechter NM: Cutaneous mast cell depletion results from topical corticos-
centrations in chronic myelogenous leukaemia. Acta Med Scand 217:89–93, 1985. teroid usage. J Immunol 135:2368–2373, 1985.
128. Anderson W, Helman CA, Hirschowitz BI: Basophilic leukemia and the hypersecretion 159. Irani AM, Craig SS, DeBlois G, et al: Deficiency of the tryptase-positive, chymase-
of gastric acid and pepsin. Gastroenterology 95:195–198, 1988. negative mast cell type in gastrointestinal mucosa of patients with defective T lympho-
129. Xue YQ, Guo Y, Lu DR, et al: A case of basophilic leukemia bearing simultaneous cyte function. J Immunol 138:4381–4386, 1987.
translocations t(8;21) and t(9;22). Cancer Genet Cytogenet 51:215–221, 1991. 160. Garriga MM, Friedman MM, Metcalfe DD: A survey of the number and distribution
130. Cecio A, Dini E, Quattrin N: Initial electron microscopy studies in 2 cases of acute of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol
basophilic leukemia. Boll Soc Ital Biol Sper 46:459–462, 1970. 82:425–432, 1988.
131. Dvorak AM, Dickersin GR, Connell A, et al: Degranulation mechanisms in human 161. Malone DG, Irani AM, Schwartz LB, et al: Mast cell numbers and histamine levels in syno-
leukemic basophils. Clin Immunol Immunopathol 5:235–246, 1976. vial fluids from patients with diverse arthritides. Arthritis Rheum 29:956–963, 1986.
132. Quattrin N: Follow-up of sixty two cases of acute basophilic leukemia. Biomedicine 162. Malone DG, Wilder RL, Saavedra-Delgado AM, et al: Mast cell numbers in rheumatoid
28:72–79, 1978. synovial tissues. Correlations with quantitative measures of lymphocytic infiltration
133. Wick MR, Li CY, Pierre RV: Acute nonlymphocytic leukemia with basophilic differen- and modulation by antiinflammatory therapy. Arthritis Rheum 30:130–137, 1987.
tiation. Blood 60:38–45, 1982. 163. Frame B, Nixon RK: Bone-marrow mast cells in osteoporosis of aging. N Engl J Med
134. Lertprasertsuke N, Tsutsumi Y: An unusual form of chronic myeloproliferative disor- 279:626–630, 1968.
der. Aleukemic basophilic leukemia. Acta Pathol Jpn 41:73–81, 1991. 164. Lennert K, Parwaresch MR: Mast cells and mast cell neoplasia: A review. Histopathology
135. Peterson LC, Parkin JL, Arthur DC, et al: Acute basophilic leukemia. A clinical, mor- 3:349–365, 1979.
phologic, and cytogenetic study of eight cases. Am J Clin Pathol 96:160–170, 1991. 165. Barrett KE, Neva FA, Gam AA, et al: The immune response to nematode parasites:
136. Shvidel L, Shaft D, Stark B, et al: Acute basophilic leukaemia: Eight unsuspected new Modulation of mast cell numbers and function during Strongyloides stercoralis infec-
cases diagnosed by electron microscopy. Br J Haematol 120:774–781, 2003. tions in nonhuman primates. Am J Trop Med Hyg 38:574–581, 1988.

Kaushansky_chapter 63_p0965-0982.indd 980 9/18/15 11:01 PM